Inventor · disambiguated record
David J. Augeri
Also filed as: AUGERI DAVID · AUGERI DAVID J · AUGERI DAVID JOHN
40 granted patents·10 pending applications·874 citations·filing 1996–2022
98Inventor score
Files withBRISTOL MYERS SQUIBB CO11UNIV RUTGERS11ABBOTT LAB8AUGERI DAVID J5LEXICON PHARMACEUTICALS INC4
Top patents by PatentIndex Score
50 records- 0199US6395767B2Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and methodBRISTOL MYERS SQUIBB CO·Filed 2001·Granted May 28, 2002·398 cites·24 claims
- 0298US6720338B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2001·Granted Apr 13, 2004·98 cites·9 claims
- 0397US7754886B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2009·Granted Jul 13, 2010·34 cites·18 claims
- 0497US7504512B2N-acylsulfonamide apoptosis promotersABBOTT LAB·Filed 2004·Granted Mar 17, 2009·58 cites·18 claims
- 0596US6670386B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 30, 2003·55 cites·11 claims
- 0692US7649098B2Imidazole-based compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2007·Granted Jan 19, 2010·20 cites·15 claims
- 0788US7420079B2Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereofBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 2, 2008·26 cites·6 claims
- 0887US7388027B2Bicyclic compounds as modulators of androgen receptor function and methodBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·9 cites·8 claims
- 0987US6992102B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jan 31, 2006·16 cites·3 claims
- 1085US10221133B2(Thio, oxo, and seleno) semicarbazone complexes with zinc and their use for treating cancerUNIV RUTGERS·Filed 2016·Granted Mar 5, 2019·6 cites·11 claims
- 1185US8093245B24-amino-1H-pyrimidin-2-one based compounds, compositions comprising them and methods of their useAUGERI DAVID J·Filed 2007·Granted Jan 10, 2012·6 cites·17 claims
- 1284US7825142B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2009·Granted Nov 2, 2010·6 cites·10 claims
- 1384US7598280B2Heterocyclic compounds, compositions comprising them and methods of their useLEXICON PHARMACEUTICALS INC·Filed 2008·Granted Oct 6, 2009·6 cites·2 claims
- 1484US6310095B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Oct 30, 2001·39 cites·14 claims
- 1583US10604481B2(Thio, oxo and seleno) semicarbazone complexes with zinc and their use for treating cancerUNIV RUTGERS·Filed 2019·Granted Mar 31, 2020·2 cites·7 claims
- 1681US10875861B1Therapeutic compoundsUNIV RUTGERS·Filed 2019·Granted Dec 29, 2020·2 cites·3 claims
- 1779US7405234B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Jul 29, 2008·9 cites·22 claims
- 1879US6204293B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Mar 20, 2001·26 cites·15 claims
- 1977US10828288B2Hydrazone derivatives for the treatment of cancerUNIV RUTGERS·Filed 2016·Granted Nov 10, 2020·2 cites·14 claims
- 2077US10729671B2Zinc complexes of hydrazones and (thio)semicarbazones and their use for the treatment of cancerUNIV RUTGERS·Filed 2016·Granted Aug 4, 2020·2 cites·13 claims
- 2177US10604480B2(Thio, oxo, and seleno) semicarbazone derivatives and their use for treating cancerUNIV RUTGERS·Filed 2016·Granted Mar 31, 2020·2 cites·28 claims
- 2277US8404732B2Methods of treating ulcerative colitisAUGERI DAVID J·Filed 2012·Granted Mar 26, 2013·3 cites·14 claims
- 2377US8153804B2Aryl pyridines and methods of their useAUGERI DAVID J·Filed 2006·Granted Apr 10, 2012·5 cites·15 claims
- 2477US6897337B2Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors thereforABBOTT LAB·Filed 2002·Granted May 24, 2005·6 cites·7 claims
- 2575US6693123B2Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 2001·Granted Feb 17, 2004·7 cites·7 claims
- 2674US10227315B2Mitochondrial uncouplers for treatment of metabolic diseases and cancerUNIV RUTGERS·Filed 2017·Granted Mar 12, 2019·1 cites·15 claims
- 2774US8093246B2O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancerAUGERI DAVID J·Filed 2007·Granted Jan 10, 2012·2 cites·18 claims
- 2874US8093267B2Methods of treating rheumatoid arthritisAUGERI DAVID J·Filed 2009·Granted Jan 10, 2012·1 cites·5 claims
- 2971US7632858B2Open chain prolyl urea-related modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Dec 15, 2009·4 cites·16 claims
- 3070US8278462B2Methods and compounds for producing dipeptidyl peptidase IV inhibitors and intermediates thereofVU TRUC CHI·Filed 2010·Granted Oct 2, 2012·2 cites·4 claims
- 3168USRE44186ECyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase IV and methodROBL JEFFREY A·Filed 2011·Granted Apr 30, 2013·1 cites·43 claims
- 3265US8440652B2MST1 kinase inhibitors and methods of their useAUGERI DAVID JOHN·Filed 2012·Granted May 14, 2013·2 cites·17 claims
- 3365US6288261B1Inhibitors of matrix metalloproteinasesABBOTT LAB·Filed 1999·Granted Sep 11, 2001·10 cites·14 claims
- 3461US7772267B2Bicyclic modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 10, 2010·0 cites·12 claims
- 3560US12427135B2Compositions and methods for inhibiting ribosome inactivating proteinsUNIV RUTGERS·Filed 2022·Granted Sep 30, 2025·0 cites·23 claims
- 3660US12215106B2Pharmaceutical compounds and therapeutic methodsUNIV RUTGERS·Filed 2019·Granted Feb 4, 2025·0 cites·3 claims
- 3757US2008108691A1Open-chain prolyl urea-related modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 3856US2008103188A1Novel bicyclic compounds as modulators of androgen receptor functionBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 3956US2013012723A1Methods and compounds for producing dipeptidyl peptidase iv inhibitors and intermediates thereofBRISTOL MYERS SQUIBB CO·Filed 2012·Application pending·0 cites
- 4055US7750004B2Apoptosis promotersABBOTT LAB·Filed 2006·Granted Jul 6, 2010·0 cites·3 claims
- 4154US7989656B2Biaryl carboxylic acid apoptosis promotersABBOTT LAB·Filed 2010·Granted Aug 2, 2011·0 cites·2 claims
- 4252US2006293229A1Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors thereforFESIK STEPHEN W·Filed 2005·Application pending·0 cites
- 4349US2022227735A1Therapeutic methods and compoundsUNIV RUTGERS·Filed 2020·Application pending·0 cites
- 4448US5831115AInhibitors of squalene synthase and protein farnesyltransferaseABBOTT LAB·Filed 1996·Granted Nov 3, 1998·8 cites·35 claims
- 4548US2011082178A1Methods of treating autoimmune and inflammatory diseases and disordersLEXICON PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 4647US2003124673A1Site-specific isotopically-labeled proteins, amino acids, and biochemical precursors thereforFiled 2002·Application pending·0 cites
- 4741US2014051681A1Mst1 kinase inhibitors and methods of their useAUGERI DAVID JOHN·Filed 2013·Application pending·0 cites
- 4841US2004019063A1Bicyclic modulators of androgen receptor functionFiled 2003·Application pending·0 cites
- 4938US10525021B2Mitochondrial uncouplers for treatment of metabolic diseases and cancerUNIV RUTGERS·Filed 2015·Granted Jan 7, 2020·0 cites·7 claims
- 5036US2002055631A1N-acylsulfonamide apoptosis promotersFiled 2001·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David J. Augeri files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →